Loading...

What to expect from health tech in India in 2016

Image

30-Dec-15 The healthcare market in India was worth close USD100 bn in 2015 and is expected to touch USD280 bn by 2020, with a CAGR of 23%. India's healthtech space has grown steadily in 2015 both in terms of funding and deal numbers. Preventive medicine is likely to see more activity in 2016 and rural India is set to emerge as a demand source. [image: Your Story]

Read More

Japanese players slow to see that data drives latest equipment trend

Image

15-Dec-15 At the recent RSNA exhibition in Chicago, GE proposed a system for information sharing across multiple settings, and Siemens devoted a big chunk of its space to the use of data, while Japanese players used the event to showcase more traditional technology. Finding ways to use data more effectively is assuming growing importance, but Japanese makers appear less interested in following this trend. [image: Nikkei Asian Review]

Read More

Indian regulators, medical device associations focus on new guidelines

Image

11-Dec-15 India’s Ministry of Health & Family Welfare (MOHFW) and the Central Drugs Standard Control Organization (CDSCO) have met with medical device association representatives to discuss how the country can become a hub for device manufacturing and begin to align with global regulations. The discussion centered on increasing device exports and evaluating new guidance for the industry. [image: RAPS]

Read More

Making healthcare accessible in Singapore

Image

11-Dec-15 Singapore will seek to improve healthcare accessibility for patients, and promote innovation in medical technology, the Minister for Trade and Industry has said. To boost healthcare accessibility, he said the healthcare workforce has to grow by 50% by 2020. Singapore will also add at least 1,700 acute beds and double the number of community hospital beds to 3,000. [image: APACMed]

Read More

China's reforms will hurt US manufacturers

Image

08-Dec-15 China's implementation of healthcare reforms, changing the approval process for new medical devices and favoring local manufacturers will restrain growth for US medical manufacturers, says Moody's. China's healthcare reforms will be particularly credit negative for companies that make complex devices, such as Medtronic, Boston Scientific and St Jude. [image: Shannon Stapleton / Reuters]

Read More
Share